Finance

Lists
Why is SLS up 2.66%?
Dive Deeper
SLS:NASDAQ
Sellas Life Sciences Group Inc
$19.66
+2.66%
(+0.51) 1D
Nov 18, 1:07:08 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLS...
Open
$19.51
High
$21.40
Low
$17.22
Mkt. cap
4.01B
Avg. vol.
10.87M
Volume
23.93M
52-wk high
$24.89
52-wk low
$1.39
EPS
-$0.20
Beta
2.73
Shares outstanding
203.86M
No. of employees
13
Open
$19.51
High
$21.40
Low
$17.22
Mkt. cap
4.01B
Avg. vol.
10.87M
Volume
23.93M
52-wk high
$24.89
52-wk low
$1.39
EPS
-$0.20
Beta
2.73
Shares outstanding
203.86M
No. of employees
13
News stories
From web sources and news partners
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to SLS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SLS in the last 3 months
Highest
Current $19.66
$40.00 (+103.46%)
Average
$40.00 (+103.46%)
Lowest
$40.00 (+103.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$40.00
+103.5%
11/17/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$25.00
+27.2%
07/06/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$25.00
+27.2%
07/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.73M
5.13M
6.27M
7.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.42M
4.12M
3.36M
4.28M
Operating expense
7.16M
9.25M
9.63M
11.31M
Total operating expenses
7.16M
9.25M
9.63M
11.31M
Operating income
-7.16M
-9.25M
-9.63M
-11.31M
Other non operating income
-
-
-
-
EBT including unusual items
-7.66M
-8.41M
-9.60M
-10.09M
EBT excluding unusual items
-6.56M
-8.41M
-8.60M
-10.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.66M
-8.41M
-9.60M
-10.09M
Net profit margin
-
-
-
-
Earnings per share
-0.05
-0.05
-0.05
-0.05
Interest and investment income
597.00K
845.00K
1.02M
1.22M
Interest expense
-
-
-
-
Net interest expenses
597.00K
845.00K
1.02M
1.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps